Generated: May 27, 2017
|Title:||Oral 2-methyl-thieno-benzodiazepine formulation|
|Abstract:||The invention provides a pharmaceutically acceptable solid oral formulation of olanzapine and a process for making such formulation.|
|Inventor(s):||Cochran; George Randall (Indianapolis, IN), Morris; Tommy Clifford (Indianapolis, IN)|
|Assignee:||Eli Lilly and Company (Indianapolis, IN)|
Patent Claim Types:|
see list of patent claims
|Formulation; Compound; Composition; Dosage form; Use; Process;|
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|African Regional IP Organization (ARIPO)||679||► Subscribe|
|African Regional IP Organization (ARIPO)||9701064||► Subscribe|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.